Driehaus Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$163K	–	442
2018 Q3	$163K	Buy	+10,000	New	+$163K	0.01%	446
2017 Q2	–	Sell	-31,790	Closed	-$145K	–	576
2017 Q1	$145K	Buy	+31,790	New	+$145K	0.01%	520